The COVID-19 pandemic and new clinical trial activations

by Joseph M. Unger, Hong Xiao
Published 2021-04-01

Dynamic zero-COVID policy and healthcare utilization patterns in China during the Shanghai COVID-19 Omicron outbreak

by Hong Xiao, Fang Liu, Joseph M. Unger
Published 2023-10-01

Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study

by Hong Xiao, Fang Liu, Joseph M. Unger
Published 2023-02-01

Feasibility of a patient-centered method to determine meaningful change in pain intensity on a survey of patients with a history of cancer

by Salene M.W. Jones, Joseph M. Unger
Published 2022-08-01

A comparison of oncologist versus mental health provider attitudes towards standardized and tailored patient-reported outcomes

by Salene M. W. Jones, Aliana Gaffney, Joseph M. Unger
Published 2021-08-01

Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index

by Zhicheng Wang, Hong Xiao, Leesa Lin, Kun Tang, Joseph M. Unger
Published 2022-07-01

Publisher Correction: Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index

by Zhicheng Wang, Hong Xiao, Leesa Lin, Kun Tang, Joseph M. Unger
Published 2022-07-01

Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls

by Yilin Chen, Xu Ji, Xu Ji, Hong Xiao, Hong Xiao, Joseph M Unger, Joseph M Unger, Yi Cai, Yi Cai, Zongfu Mao, Kai Yeung, Kai Yeung
Published 2021-12-01

A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma.

by Lisa M Rimsza, Joseph M Unger, Margaret E Tome, Michael L Leblanc
Published 2011-01-01

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?

by Katherine D. Crew, Kathy S. Albain, Dawn L. Hershman, Joseph M. Unger, Shelly S. Lo
Published 2017-05-01

Feasibility and Validity of Asking Patients to Define Individual Levels of Meaningful Change on Patient-Reported Outcomes

by Salene M.W. Jones, Yuxian Du, Ari Bell-Brown, Kaylin Bolt, Joseph M. Unger
Published 2020-07-01

Unequal impact of the COVID-19 pandemic on paediatric cancer care: a population-based cohort study in China

by Hong Xiao, Fang Liu, Yao He, Xiaochen Dai, Zhenhui Liu, Weiyan Jian, Joseph M. Unger
Published 2022-02-01

A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events

by Shing M. Lee, Jieling Miao, Ruby Wu, Joseph M. Unger, Ken Cheung, Dawn L. Hershman
Published 2019-08-01

The impact of the SARS-COV-2 pandemic on health services utilization in China: Time-series analyses for 2016–2020

by Hong Xiao, Xiaochen Dai, Bradley H. Wagenaar, Fang Liu, Orvalho Augusto, Yan Guo, Joseph M Unger
Published 2021-04-01

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era

by Michael E. Roth, Joseph M. Unger, Ann M. O'Mara, Mark A. Lewis, Troy Budd, Rebecca H. Johnson, Brad H. Pollock, Charles Blanke, David R. Freyer
Published 2020-03-01

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

by Christopher J. Stasik, Hiroaki Nitta, Wenjun Zhang, Charles H. Mosher, James R. Cook, Raymond R. Tubbs, Joseph M. Unger, Tracy A. Brooks, Daniel O. Persky, Sarah T. Wilkinson, Thomas M. Grogan, Lisa M. Rimsza
Published 2010-04-01

Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey

by Shellie D. Ellis, Riha Vaidya, Joseph M. Unger, Kelly Stratton, Jessie Gills, Peter Van Veldhuizen, Eileen Mederos, Emily V. Dressler, Matthew F. Hudson, Charles Kamen, Heather B. Neuman, Anne E. Kazak, Ruth C. Carlos, Kathryn E. Weaver
Published 2022-10-01

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)

by Jennifer M. Mongiovi, Gary R. Zirpoli, Rikki Cannioto, Lara E. Sucheston-Campbell, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobagyi, Julie R. Gralow, G. Thomas Budd, Kathy S. Albain, Christine B. Ambrosone, Susan E. McCann
Published 2018-11-01

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase II...

by Joseph M. Unger, Katherine Griffin, Gary W. Donaldson, Karen M. Baranowski, Margorie J. Good, Eunicia Reburiano, Maha Hussain, Paul J. Monk, Peter J. Van Veldhuizen, Michael A. Carducci, Celestia S. Higano, Primo N. Lara, Catherine M. Tangen, David I. Quinn, James L. Wade, III, Nicholas J. Vogelzang, Ian M. Thompson, Jr, Carol M. Moinpour
Published 2018-06-01

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI...

by Siu-Fun Wong, Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries, Anna Moseley, Kathryn Arnold, Mario R. Velasco, Justin D. Floyd, Benjamin T. Esparaz, Afsaneh Barzi, Heinz-Josef Lenz, Marianna Koczywas, Shaker Dakhil, Gary V. Burton, Michael J. Fisch, N. Lynn Henry, Dawn L. Hershman, Carol M. Moinpour
Published 2020-07-01